Author/Authors :
Michael J. Costanzo، نويسنده , , Stephen C. Yabut، نويسنده , , Han-Cheng Zhang، نويسنده , , Kimberley B. White، نويسنده , , Lawrence de Garavilla، نويسنده , , Yuanping Wang، نويسنده , , Lisa K. Minor، نويسنده , , Brett A. Tounge، نويسنده , , Alexander N. Barnakov، نويسنده , , Frank Lewandowski، نويسنده , , Cynthia Milligan، نويسنده , , John C. Spurlino، نويسنده , , William M. Abraham، نويسنده , , Victoria Boswell-Smith، نويسنده , , Clive P. Page، نويسنده , , Bruce E. Maryanoff، نويسنده ,
Abstract :
We have explored a series of spirocyclic piperidine amide derivatives (5) as tryptase inhibitors. Thus, 4 (JNJ-27390467) was identified as a potent, selective tryptase inhibitor with oral efficacy in two animal models of airway inflammation (sheep and guinea pig asthma models). An X-ray co-crystal structure of 4 • tryptase revealed a hydrophobic pocket in the enzyme’s active site, which is induced by the phenylethynyl group and is comprised of amino acid residues from two different monomers of the tetrameric protein.
Keywords :
inhibitor , Spiropiperidine , tryptase , asthma